FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used for treating patients with non-coronarogenic ventricular parasystole recorded at rest. A physical exercise (PE) test is performed; in case of parasystole progressing during exercise, a repeated test with PE is performed 60 minutes after the patient took β-adrenergic blockers (β-AB) of short action. If the load parasystole decreases or disappears, but the rest parasystole persists, drug therapy is performed β- AB with its administration in the first half of the day and an IC class preparation with an anticholinergic effect – in the second half. Antiarrhythmic efficacy, safety of treatment and selection of doses of preparations is carried out by results of multi-day ECG telemonitoring for 5–6 days.
EFFECT: method provides higher clinical effectiveness in non-coronarogenic ventricular parasystole with simultaneous reduction of risks of developing side and arrhythmogenic effects when using two antiarrhythmic preparations by determining the mixed nature of ventricular parasystole and a combination of group preparations β-AB and IC class with anticholinergic effect.
1 cl, 2 ex
